Dobutamine in the Management of Advanced Heart Failure
Open Access
- 27 June 2024
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (13) , 3782
Abstract
Background: The potential harm and clinical benefits of inotropic therapy in patients with decompensated heart failure with reduced ejection fraction or advanced heart failure were debated for three decades. Nonetheless, confronted with a dismal quality of life in the last months to years of life, continuous home inotropic therapy has recently gained traction for palliative therapy in patients who are not candidates for left ventricular mechanical circulatory support or heart transplantation. Methods: As continuous inotropic therapy is only considered for patients who experience symptomatic relief and display objective evidence of improvement, clinical equipoise is no longer present, and randomized controlled trials are hard to conduct. Results: We first outline the transient use of inotropic therapy in patients with decompensated heart failure with reduced ejection fraction and emphasize the hemodynamic requisite for inotropic therapy, which is a demonstration of a low cardiac output through a low mixed venous oxygen saturation. Lastly, we review the current experience with the use of home inotropic therapy in patients who are not candidates or are awaiting mechanical circulatory support or heart transplantation. Conclusions: Evidence-based clinical data are needed to guide inotropic therapy for refractory decompensated heart failure with reduced ejection fraction in patients who are ineligible or awaiting mechanical circulatory support or heart transplantation.Keywords
This publication has 61 references indexed in Scilit:
- INFLUENCE OF CARDIAC OUTPUT ON THE CORRELATION BETWEEN MIXED VENOUS AND CENTRAL VENOUS OXYGEN SATURATIONBritish Journal of Anaesthesia, 1992
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Incidence and significance of a “step-down” in oxygen saturation from superior vena cava to pulmonary arteryThe American Journal of Cardiology, 1991
- Acute effects of intravenous milrinone in heart failureEuropean Heart Journal, 1989
- The value of mixed venous oxygen saturation as a therapeutic indicator in the treatment of advanced congestive heart failureAmerican Heart Journal, 1987
- Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failureJACC, 1986
- Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.Journal of Clinical Investigation, 1985
- Should the Failing Heart Be Stimulated?New England Journal of Medicine, 1984
- Critical Assessment of Use of Central Venous Oxygen Saturation as a Mirror of Mixed Venous Oxygen in Severely Ill Cardiac PatientsCirculation, 1969
- Measurement of Central Venous Oxygen Saturation in Patients with Myocardial InfarctionCirculation, 1968